Catalytically potent and selective clusterzymes for modulation of neuroinflammation through single-atom substitutions.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33414464.
- Also identified by DOI 10.1038/s41467-020-20275-0 and PMC identifier 7791071.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Emerging artificial enzymes with reprogrammed and augmented catalytic activity and substrate selectivity have long been pursued with sustained efforts. The majority of current candidates have rather poor catalytic activity compared with natural molecules. To tackle this limitation, we design artificial enzymes based on a structurally well-defined Au<sub>25</sub> cluster, namely clusterzymes, which are endowed with intrinsic high catalytic activity and selectivity driven by single-atom substitutions with modulated bond lengths. Au<sub>24</sub>Cu<sub>1</sub> and Au<sub>24</sub>Cd<sub>1</sub> clusterzymes exhibit 137 and 160 times higher antioxidant capacities than natural trolox, respectively. Meanwhile, the clusterzymes demonstrate preferential enzyme-mimicking catalytic activities, with Au<sub>25</sub>, Au<sub>24</sub>Cu<sub>1</sub> and Au<sub>24</sub>Cd<sub>1</sub> displaying compelling selectivity in glutathione peroxidase-like (GPx-like), catalase-like (CAT-like) and superoxide dismutase-like (SOD-like) activities, respectively. Au<sub>24</sub>Cu<sub>1</sub> decreases peroxide in injured brain via catalytic reactions, while Au<sub>24</sub>Cd<sub>1</sub> preferentially uses superoxide and nitrogenous signal molecules as substrates, and significantly decreases inflammation factors, indicative of an important role in mitigating neuroinflammation.
Medical subject headings
- Enzymes
- Inflammation
- Neurons
- Organometallic Compounds